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A simple reversed phase high-performance liquid chromatographic (RP-HPLC) method coupled with a photodiode array detector
(PAD) has been developed and validated for the analysis of hederacoside C, the marker of ivy plant, in Ivy-Thyme cough syrup.
Separation of hederacoside C was achieved using a Phenomenex-Gemini C18 column isothermally at 40
◦C. A mobile phase
system constituted of solvent A (water: acetonitrile: orthophosphoric acid (85%), 860:140:2v/v) and solvent B (acetonitrile:
orthophosphoric acid (85%), 998:2v/v) was used, at gradient conditions, at a ﬂow rate of 1.5mL/min. Analysis was performed
using UV-detection (205nm). The method was linear over the range (0.03–0.15)mg/mL of hederacoside C (r = 0.9992).
Repeatability and intermediate precision were acceptable (RSD < 2%). Limits of detection (LOD) and quantitation (LOQ) were
0.011and0.032mg/mL,respectively.Percentagerecoverywasfoundtoliebetween99.69%and100.90%(RSD < 2%).Themethod
was also proved to be speciﬁc (peak-purity coeﬃcient = 0.996).
1.Introduction
In recent years there has been a growing interest in the
therapeutic use of herbal medicines or phytopharmaceutical
products [1, 2]. The reasons of such interest can be referred
mainly to the fears of abuse and misuse of synthetic drugs,
the side eﬀects or ineﬃcacy of conventional medicine, the
access to conventional pharmacological treatment is not
available to whole population, and the suggestions regarding
the safety of natural products [3].
Ivy-Thyme cough syrup is an herbal medicine that
combines the extract of Hedera helix (English ivy, family:
Lamiaceae) leaves along with the extract of Thymus vulgaris
(thyme, family: Araliaceae) herb for the purpose of cough
treatment. As a medicinal plant, H. helix leaf extract is
approved by the German Commission E [4]f o ri t se ﬃcacy
against chronic inﬂammatory bronchial conditions and
productive coughs due to its actions as an expectorant and
itsspasmolyticeﬀectamongchildrenandadults[5,6].These
eﬀects are attributable, in particular, to the therapeutically
important constituents of the ivy leaf extract, which belong
to the class of triterpene saponins such as hederacoside C
(Figure 1), a marker and an active ingredient of ivy leaf
extract [7–10]. On the other hand, thyme is a medicinal
herb whose leaf extract is approved by commission E in
the treatment of bronchitis, whooping cough, and upper
respiratory inﬂammation. Thyme and its various extracts
are well known for their bronchospasmolytic, expectorant,
and antibacterial eﬀects [11]. These latter eﬀects are most
likely attributed to the phenolic components (thymol and
carvacrol) of the plant volatile oil [12, 13].
To evaluate the quality of herbal medicines, reliable
analytical methods have to be applied to the quantitative
determination of the constituents with known therapeutic2 International Journal of Analytical Chemistry
a c t i v i t yo rt ot h em a r k e r si nﬁ n a lp r o d u c t s[ 1, 14]. For the
quality control of Ivy-Thyme cough syrup, hederacoside C
andthymol,theactivemarkersofivyandthyme[15],respec-
tively, are needed to be quantiﬁed by a validated method in
order to determine the contents of their corresponding plant
extracts in the ﬁnished product.
Accordingly, the objective of the present study was to
develop a simple, reliable, and validated analytical method
forthequantiﬁcationofhederacosideC,themarkerofivy,by
theuseofhigh-performanceliquidchromatography(HPLC)
with UV detection, a method that can be used eﬃciently for
routine quality control and analysis of such herbal product.
Actually, the challenge in the development of such a
method is attributed to the presence of hederacoside C
in a complex matrix of the cough syrup. It seems that
the presence of other saponins from other extracts (e.g.
thyme extract) used in cough preparations as well as other
ingredients of the cough syrup may interfere with the
chromatographic peak of hederacoside C and, thus, its
quantiﬁcation. These factors increase the complexity of
analysis and necessitate the development of a new analytical
method for the accurate quantiﬁcation of hederacoside C,
the quality marker of ivy.
2. Experimental
2.1. Instrumentation. The HPLC system used was a Shi-
madzu CLASS-VP System equipped with a model series
LC-10 ADVP Pump, FCV-10ALVP Low pressure gradient
ﬂow controller valve, SCL-10 ADVP controller, 50μLl o o p
injector,CTO-10Ascolumnoven,andaSPD-M10AVPdiode
array detector. Data acquisition was performed on class-VP
software.
2.2. Materials and Reagents. The standardized raw material
of Hedera helix leaves (standardized to contain 14.8% of
hederacoside C) was supplied by Fenzilberg (Germany),
hederacoside C standard with purity of more than 99%
waspurchasedfromPhytoplan(Germany),orthophosphoric
acid(H3PO4)85%fromMerck(Germany),ﬁltermembranes
were purchased from Vivid (PTFE/0.45μm/25mm diame-
ter), Ivy-Thyme cough syrup (potency: 0.7mg hederacoside
C and 0.2mg thymol per 1mL syrup), and placebo were
generously provided by Sana Pharmaceutical Research Co.
(Jordan). All solvents used were of HPLC grade; acetonitrile
and methanol gradient grade were purchased from Scharlau
(Spain), bidistilled water was produced via a Bi-Dest 2302
GFL (Germany).
2.3. HPLC Conditions. The column was a reversed-phase
Phenomenex-Gemini C18 (250 × 4.6mmi.d.; 5μm)
equipped with a Phenomenex security guard column (4.0 ×
3.0mmi.d.). For HPLC separation, the mobile phase con-
sisted of a binary mixture of solvent-A (H2O:ACN:H 3PO4)
in the ratio of (860:140:2) and solvent-B (ACN:H3PO4)
in the ratio of (998:2) with a gradient program as follows:
0–60% B (0–40min), 60–100% B (40–41min), 100% B
isocratic (41–55min), and return to 0% B (55-56min),
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Figure 1: Chemical structure of hederacoside C (3-[[2-O-(α-L-
Rhamnopyranosyl)-α-L-arabinopyranosyl]oxy]-23-hydroxyolean-
12-en-28-oic acid 6-O-[4-O-(α-L-rhamnopyranosyl)-β-D-
glucopyranosyl]-β-D-glucopyranosyl ester).
and ﬁnally, reconditioning the column with 0% B isocratic
(55–70min). The analysis was performed at a ﬂow rate of
1.5mL/min. Injection was manual and the injection volume
was 50μL. The UV detector was set at 205nm and separation
was performed isothermally at 40
◦C. All samples and
standards injected are ﬁltered through 0.45μmm e m b r a n e
ﬁlter.
2.4. Reference Solution. A reference solution of hederacoside
C was prepared at a concentration of 1.0mg/mL by transfer-
ring 10mg of hederacoside C to a 10mL volumetric ﬂask,
methanol was added, and the solution was sonicated for
10min then completed to volume.
2.5. Standard Solutions. Hederacoside C stock solution
containing 1.0mg/mL of hederacoside C was prepared by
transferring 3.378g of standardized Ivy raw material powder
(containing 14.8% hederacoside C) in 500mL volumetric
ﬂask, ﬁlled up to 80% of its volume with methanol, then
it was sonicated for 30 minutes in the ultrasonic bath to
dissolve hederacoside C. After cooling to room temperature,
the volume was ﬁlled up to the mark with methanol.
Calibration standard solutions with diﬀerent concentrations
were prepared by appropriate dilutions from the stock using
methanol as the diluent.
2.6.SamplePreparation. 1.7gofIvy-Thymecoughsyrupwas
weighed in 10mL volumetric ﬂask, ﬁlled with 80% of the
volume with methanol, sonicated for 15min to homogenize
the solution in ultrasonic bath, and after cooling to room
temperature the ﬂask was ﬁlled up to the mark. According
to this procedure, the ﬁnal solution is supposed to have a
concentration of 0.1mg/mL hederacoside C.International Journal of Analytical Chemistry 3
3. Results andDiscussion
3.1. Method Development. Challenges in the development of
an HPLC method with eﬃcient separation of hederacoside C
incoughsyrupincludeitsseparationfromasaponinmixture
coming from ivy extract along with its separation from
other saponins present in the thyme extract. In addition,
hederacoside C, like almost all other saponins, lacks a
chromophore; it absorbs UV-light at wavelengths below
210nm [8, 16], which makes its detection in a complex
matrix of a herbal product along with its analysis by the use
of gradient elution not an easy task [17].
To the best of our knowledge, the present study is
the ﬁrst to report a validated method for the analysis of
ivy extract in pharmaceutical products (syrup) and the
ﬁrst on ivy-thyme mixture. In literature, analysis of Ivy
plant and extracts, using hederacoside C as a marker, has
been generally performed by means of RP-HPLC and UV
detection (wavelengths below 210nm) based mainly on
C18 columns under gradient elution [6, 17, 18]. For the
analysis of other types of saponins, some of which from
other natural sources, comparable methods with modiﬁed
conditions, solvent systems or detector were also developed
a n dr e p o r t e d[ 16, 19]. Unfortunately, reproducing these
methods to the analysis of Ivy-Thyme syrup under study was
always unsuccessful.
In the present study, the developed HPLC method
ensuredsuﬃcientchromatographic separation(Figure2(a)),
and accurate and precise quantiﬁcation of hederacoside C.
Moreover, the use of UV detector, the most common type of
detectors used with HPLC instruments [14, 20], makes the
developed method a simple and suitable method for routine
quality control of ivy-based cough syrups.
3.2. Validation of the HPLC Method. The developed method
was validated according to the guidelines of the International
Conference on Harmonization (ICH) for validation of
analytical procedures [21]a n dU S P[ 22] for its linearity,
precision, accuracy, and speciﬁcity.
3.2.1. Range. The calibration range over which the analysis
should be validated is determined according to the purpose
of the analysis. For the quantiﬁcation of an active ingredient
in ﬁnal product, hederacoside C in cough syrup; the
suggested range to be covered according to ICH guidelines
is 80%–120% of the test concentration. In our experiment
the chosen range was (0.03–0.15)mg/mL of hederacoside
C, which corresponds to a range of 30%–150% of the test
concentration (0.1mg/mL).
3.2.2. Linearity. The linearity of the HPLC method for
determination of hederacoside C was evaluated by analyzing
as e r i e so fd i ﬀerent concentrations of hederacoside C.
According to ICH guidelines, at least ﬁve concentrations
must be used covering the speciﬁed range. In the present
experiment, seven diﬀerent concentrations of hederacoside
C were chosen, covering the range of (0.03–0.15)mg/mL
of hederacoside C. Each concentration was injected in
Table 1: Linear regression data of the HPLC method for the
determination of hederacoside C in Ivy-Thyme cough syrup.
Parameter
∗ Value
Calibration range (mg/mL) 0.03–0.15
Regression equation slope 4612.8
y-Intercept 5000.3
Correlation coeﬃcient (r) 0.9992
∗Linear regression equation: y = 4612.8x + 5000.3.
Table 2: Repeatability and intermediate precision of the HPLC
method for the determination of hederacoside C in Ivy-Thyme
cough syrup.
Retention
time mean
(min)±SD
n = 6
Concentration
mean
(mg/mL)
n = 6
CV (%)
(repeatability)
CV (%)
(intermediate
precision)
26.0 ±0.1 0.1 1.83 1.81
n: Number of determinations (number of sample solutions (at 0.1mg/mL)
prepared and injected).
SD: Standard deviation.
CV: Coeﬃcient of variation (RSD).
duplicate. The method was found linear over the speciﬁed
range with a correlation coeﬃcient (r) value of 0.9992
(Table 1).
3.2.3. Precision. For the evaluation of method precision,
repeatability and intermediate precision were performed at
100%ofthetestconcentrationasguidedbyICH.Sixsamples
ofthedrug,at0.1mg/mLconcentrationlevelofhederacoside
C, were prepared and analyzed by the developed method at
the same day for repeatability assessment, and then repeated
24 hours apart for the evaluation of intermediate precision.
Coeﬃcient of variation (or relative standard deviation, RSD)
has been calculated, the results indicated that the developed
method was with acceptable precision (Table 2).
3.2.4. Speciﬁcity. Injection of sample placebo (consisting of
all matrix components with the exception of hederacoside
C) in duplicate under the conditions of the developed HPLC
method showed that there was no interference from sample
matrix (Figure 2(b). In addition, peak purity testing of
hederacoside C showed that the peak refers only to one
component with peak-purity coeﬃcient of 0.996. So the
method was considered to be speciﬁc for hederacoside C
analysis.
3.2.5. Accuracy. This test was performed by the addition of
known amounts of the hederacoside C standard to cough
syrup placebo. The resulting mixtures, at three diﬀerent
concentrationlevelscoveringthemethodrange,wereassayed
by the developed method analyzing 6 replicates at each
concentration. The good recovery values obtained and their
low RSD (less than 2%, Table 3) suggested that the accuracy
of the proposed method was acceptable.4 International Journal of Analytical Chemistry
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Figure 2: Liquid chromatograms of (a) Ivy-Thyme cough syrup
sample and (b) Ivy-Thyme cough syrup placebo.
Table 3: Accuracy of the HPLC method for the determination of
hederacoside C in Ivy-Thyme cough syrup placebo.
Level % Recovery Mean (n = 6) CV (%) n = 6
30% 100.45 1.81
100% 100.90 1.66
150% 99.69 0.67
CV: Coeﬃcient of variation (RSD).
n: Number of determinations (number of sample solutions prepared and
injected).
3.2.6. Limits of Detection (LOD) and Quantitation (LOQ).
Based on the values of standard deviation of the response
(SD), calculated as the standard deviation of y-intercepts
of regression lines, and slope (S) obtained from the linear
regression equation described above, the LOD and LOQ
values were calculated, according to the ICH guidelines, as
follows:
LOD = 3.3 ∗

SD
S

,
LOQ = 10 ∗

SD
S

.
(1)
From these data, shown in Table 4, the developed method
proved to be suitable for detection and quantitative determi-
nationofevenverylowdrugcontents(LOD = 0.011mg/mL,
and LOQ = 0.032mg/mL). A validation of the calculated
LOQ, as according to ICH guidelines, was also performed
by the analysis, in duplicate, of 6 samples containing
hederacoside C at the concentration of 0.03mg/mL. The
method proved to be with good repeatability (CV = 1.88)
and intermediate precision (CV = 1.93) at the calculated
LOQ. On the other hand, linearity and accuracy parameters
were not tested because the calculated LOQ already occurs
within the tested drug range (0.03–0.15mg/mL) for these
two parameters conducted as above.
Table 4: Limits of detection (LOD) and quantitation (LOQ) of
the HPLC method for the determination of hederacoside C in Ivy-
Thyme cough syrup.
Standard deviation of the
response (SD
∗)
LOD
a (mg/mL) LOQ
a (mg/mL)
14831.8 0.011 0.032
∗The value of SD was calculated as the standard deviation of y intercepts of
regressionlinesplotted,atthechromatographicresponsesofthecalibration
solutions (0.03–0.15mg/mL), parallel to the calibration curve (slope =
4612.8).
aFor calculation of LOD and LOQ values, see Results and Discussion.
4. Conclusions
A simple and reliable reversed phase high-performance
liquid chromatographic method with UV detection for the
quantiﬁcation of hederacoside C, in the cough syrup has
been developed and validated for its linearity, precision,
speciﬁcity, and accuracy, providing a suitable and practical
analytical method for the routine quality control analyses
necessary for providing herbal medicines with high safety
and eﬃcacy.
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